The study of the spectrum of pharmacological activity of the new original NT-3 mimetic dipeptide GTS-302
暂无分享,去创建一个
T. Gudasheva | P. Povarnina | S. Seredenin | J. V. Vakhitova | L. Kolik | A. Nadorova | E. Valdman | Dmitrii M. Nikiforov
[1] A. V. Tarasiuk,et al. The First Dipeptide Mimetic of Neurotrofin-3: Design and Pharmacological Properties , 2022, Doklady Biochemistry and Biophysics.
[2] Hui Wang,et al. Neurotrophin-3 Promotes the Neuronal Differentiation of BMSCs and Improves Cognitive Function in a Rat Model of Alzheimer's Disease , 2021, Frontiers in Cellular Neuroscience.
[3] A. Teixeira,et al. Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety? , 2020, Expert opinion on therapeutic targets.
[4] T. Gudasheva,et al. Low‐molecular mimetics of nerve growth factor and brain‐derived neurotrophic factor: Design and pharmacological properties , 2020, Medicinal research reviews.
[5] I. Naletova,et al. Copper complexes of synthetic peptides mimicking neurotrophin-3 enhance neurite outgrowth and CREB phosphorylation. , 2019, Metallomics : integrated biometal science.
[6] A. Araszkiewicz,et al. Melatonin and neurotrophins NT-3, BDNF, NGF in patients with varying levels of depression severity , 2016, Pharmacological reports : PR.
[7] Maria V. Sanchez-Vives,et al. Infralimbic Neurotrophin-3 Infusion Rescues Fear Extinction Impairment in a Mouse Model of Pathological Fear , 2016, Neuropsychopharmacology.
[8] A. Wysokiński. Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia , 2016, Nordic journal of psychiatry.
[9] P. Povarnina,et al. Dimeric dipeptide mimetics of the nerve growth factor Loop 4 and Loop 1 activate TRKA with different patterns of intracellular signal transduction , 2015, Journal of Biomedical Science.
[10] M. Escobar,et al. Plasticity and metaplasticity of adult rat hippocampal mossy fibers induced by neurotrophin‐3 , 2013, The European journal of neuroscience.
[11] J. Zhang,et al. Neuroprotection of neurotrophin-3 against focal cerebral ischemia/reperfusion injury is regulated by hypoxia-responsive element in rats , 2012, Neuroscience.
[12] M. Antunes,et al. The novel object recognition memory: neurobiology, test procedure, and its modifications , 2011, Cognitive Processing.
[13] F. Kapczinski,et al. Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes. , 2010, Journal of psychiatric research.
[14] Yu-Chin Li,et al. Bivalent peptidomimetic ligands of TrkC are biased agonists and selectively induce neuritogenesis or potentiate neurotrophin-3 trophic signals. , 2009, ACS chemical biology.
[15] M. Gratacós,et al. Allele variants in functional MicroRNA target sites of the neurotrophin‐3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders , 2009, Human mutation.
[16] W. Pan,et al. Peptides and Hormesis , 2008, Critical reviews in toxicology.
[17] A. Walf,et al. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents , 2007, Nature Protocols.
[18] R. Jaenisch,et al. NT-3 facilitates hippocampal plasticity and learning and memory by regulating neurogenesis. , 2006, Learning & memory.
[19] K. Burgess,et al. New templates for syntheses of ring-fused, C(10) beta-turn peptidomimetics leading to the first reported small-molecule mimic of neurotrophin-3. , 2002, Journal of medicinal chemistry.
[20] E. Huang,et al. Expression of Trk receptors in the developing mouse trigeminal ganglion: in vivo evidence for NT-3 activation of TrkA and TrkB in addition to TrkC. , 1999, Development.
[21] G. L. Curran,et al. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. , 1996, Brain research. Molecular brain research.
[22] N. Seidah,et al. Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases , 1996, FEBS letters.
[23] C. Altar,et al. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine , 1994 .
[24] J. Siuciak,et al. Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3 , 1994, Brain Research.
[25] S. File,et al. Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.
[26] S. Handley,et al. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ‘fear’-motivated behaviour , 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.
[27] R. Porsolt,et al. Behavioural despair in rats: a new model sensitive to antidepressant treatments. , 1978, European journal of pharmacology.
[28] K. Montgomery,et al. The relation between fear induced by novel stimulation and exploratory drive. , 1955 .
[29] M. Gratacós,et al. 5′ UTR-region SNP in the NTRK3 gene is associated with panic disorder , 2002, Molecular Psychiatry.